The new manufacturing facility is said to be ideally located to better distribute Seppic’s thickening and texturising agents globally
Air Liquide Healthcare-owned ingredients supplier Seppic has inaugurated its first production site in the US.
The plant, which is already in operation, has provided France-headquartered Seppic with more than 50% additional production capacity for thickening and texturising agents.
Located near Richmond, Virginia, the site is said to be ideally located to service the north-eastern US, where 80% of Seppic’s US customers are based, as well as to export globally.
The facility has been designed to abide by the highest levels of quality in compliance with Good Manufacturing Practices (GMP) and has obtained ISO 9001, EFfCI and RSPO certifications.
Jean-Baptiste Dellon, CEO of Seppic, said: “With this new plant, we increase our industrial capacity and our ability to serve our customers in the US and all over the world.
"This cutting-edge plant is in compliance with Seppic’s strategy to produce high performance ingredients while respecting the environment.
“Our ambition in terms of CSR is to continue to meet our customers’ needs while achieving an objective of reducing our waste and energy consumption.”